​

Jade Biosciences Ownership | Who Owns Jade Biosciences?

OverviewFinancialsChart

Jade Biosciences Ownership Summary

Jade Biosciences is owned by 134144.16% institutional investors, 0.04% insiders.

JBIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockJade Biosciences134144.16%0.04%-134044.20%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202532-6,707,208-134,144-32---

Recent Insider Transactions

DateNameRoleActivityValue
May 16, 2025Frohlich Tom Chief Executive OfficerBuy$44.40K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q21-

JBIO Ownership FAQ

Who Owns Jade Biosciences?

Jade Biosciences shareholders are primarily institutional investors at 134144.16%, followed by 0.04% insiders and -134044.20% retail investors. The average institutional ownership in Jade Biosciences's industry, Biotech Stocks , is 306.59%, which Jade Biosciences exceeds.

Does Blackrock own Jade Biosciences?

BlackRock is not among the top 10 institutional shareholders of Jade Biosciences.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools